Skip to content

A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19)

Hospital of Chengdu University of Traditional Chinese Medicine jointly launched a real-world study on the clinical efficacy evaluation of the Inner hospital preparation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030936
Enrollment
Unknown
Registered
2020-03-18
Start date
2020-03-10
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. During the outbreak of new coronavirus pneumonia, patients with fever caused by respiratory infection (body temperature > 37 degree C), whether or not they are suspected or confirmed cases of new coronary pneumonia; 2. Comply with the diagnostic criteria of TCM for wind-heat and dampness or wind-cold and dampness syndrome; 3. Aged 18 to 75 years; 4. Outpatients or inpatients admitted by second-level and above medical institutions; 5. Voluntarily joined the study, with good compliance and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Known allergies to the components of this study; 2. Non-fever non-new coronary pneumonia diagnosed or suspected; 3. Fever caused by other non-infectious causes; 4. Patients with tuberculosis, bronchial asthma, chronic obstructive pulmonary disease, and respiratory failure; 5. Patients who are unwilling to take traditional Chinese medicine preparations; 6. Women during pregnancy and lactation who have fertility requirements in the last 3 months; 7. Participating in clinical trials of other drugs; 8. Other reasons led the researchers to consider it inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Body temperature returns to normal time;After the medication, the disappearance rate of TCM symptoms;

Countries

China

Contacts

Public ContactPeiyang Gao

Hospital of Chengdu University of Traditional Chinese Medicine

gaopy930@126.com+86 18980025566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026